600222 太龙药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.5993.2052.766-4.4700.385
总资产报酬率 ROA (%)0.7011.4301.213-1.9540.167
投入资产回报率 ROIC (%)0.9441.9701.775-2.5040.189

边际利润分析
销售毛利率 (%)24.29025.59327.28224.07728.860
营业利润率 (%)2.9101.8402.134-3.6102.219
息税前利润/营业总收入 (%)6.6114.7734.662-0.9845.701
净利润/营业总收入 (%)2.5682.7552.166-3.8640.422

收益指标分析
经营活动净收益/利润总额(%)58.09956.06879.25640.946909.530
价值变动净收益/利润总额(%)3.48430.433-14.95213.385-87.463
营业外收支净额/利润总额(%)-0.689-1.839-2.80314.568-377.957

偿债能力分析
流动比率 (X)1.1551.0621.2081.1771.178
速动比率 (X)0.9040.8570.9320.9160.947
资产负债率 (%)55.87653.40054.61455.24853.019
带息债务/全部投入资本 (%)38.52439.08130.32733.42139.474
股东权益/带息债务 (%)154.661149.609213.566190.278127.520
股东权益/负债合计 (%)76.25584.50380.80578.81482.772
利息保障倍数 (X)1.7771.6091.803-0.3041.089

营运能力分析
应收账款周转天数 (天)217.627153.986126.000112.925113.166
存货周转天数 (天)127.153102.572108.344100.644115.115